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Abstract
Cardiometabolic diseases, which include obesity, diabetes, hypertension and cardiovascular 
disease, are associated with reduced quality of life and reduced life expectancy. Unfortunately, 
racial/ethnic and socioeconomic disparities in these diseases exist such that minority populations, 
such as African Americans and Hispanics, and those of lower socioeconomic status, experience a 
greater burden. Several reports have indicated that there are differences in sleep duration and 
quality that mirror the disparities in cardiometabolic disease. The goal of this paper is to review 
the association between sleep and cardiometabolic disease risk because of the possibility that 
suboptimal sleep may partially mediate the cardiometabolic disease disparities. We will review 
both experimental studies that have restricted sleep duration or impaired sleep quality and 
examined biomarkers of cardiometabolic disease risk, including glucose metabolism and insulin 
sensitivity, appetite regulation and food intake, and immune function. We will also review 
observational studies that have examined the association between habitual sleep duration and 
quality and the prevalence or risk of obesity, diabetes, hypertension and cardiovascular disease. 
Many experimental and observational studies do support an association between suboptimal sleep 
and increased cardiometabolic disease risk.
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1. Introduction
Cardiometabolic disease refers to obesity, diabetes and cardiovascular disease (CVD), which 
are grouped together because they are related and share risk factors. For example, 
approximately 70% of total mortality in type 2 diabetes is due to cardiovascular disease, and 
individuals with the metabolic syndrome, which is a clustering of risk factors including 
obesity, dyslipidemia, high blood pressure and insulin resistance, are at increased risk of 
developing type 2 diabetes and CVD [1]. Unfortunately, the prevalence of these diseases is 
not distributed equally among the different racial/ethnic and socioeconomic groups in the 
US. Obesity rates are higher in African Americans (45%) and Mexican-Americans (36.8%) 
compared to whites (30%) [2] and African-Americans and Mexican-Americans are at 
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greater risk of developing diabetes compared to non-Hispanic whites [3]. The prevalence of 
hypertension is also higher among African-American adults compared to non-Hispanic 
whites [4]. Persons with lower socioeconomic status are also at an increased risk of 
cardiometabolic disease [5, 6]. Cardiometabolic disease is associated with reduced quality of 
life, decreased life expectancy and increased economic burden [7–10] and due to the 
disparities in cardiometabolic disease, minorities and people from lower socioeconomic 
groups suffer a greater burden.
There are disparities in optimal sleep duration and sleep quality that parallel the disparities 
in cardiometabolic disease. Minority groups, particularly African Americans, have shorter 
habitual sleep duration and poorer habitual sleep quality based on objectively-measured 
wrist actigraphy compared to non-Hispanic whites [11, 12]. In addition, several studies that 
used polysomnography (PSG) consistently observed lower amounts of slow wave sleep and 
reduced sleep efficiency among African Americans compared to non-Hispanic whites [13–
16]. A recent meta-analysis of data from 14 studies that enrolled people without suspected 
sleep disorders and used either actigraphy or PSG demonstrated that on average African 
Americans sleep almost 30 minutes less, take 6 minutes longer to fall sleep, have 5% lower 
sleep efficiency and have 8% less SWS than non-Hispanic whites [17]. In addition, sleep 
disorders such as obstructive sleep apnea (OSA) may be more common, go undiagnosed 
more frequently and may be treated less efficaciously in African American patients [18, 19]. 
OSA is associated with poor sleep quality and often reduced sleep duration. Papers in this 
special issue also report sleep disparities.
Thus, cardiometabolic disease disparities and sleep disparities seem to exist, which begs the 
question of whether suboptimal sleep may partially mediate the cardiometabolic disease 
disparities. In order for this to be true, suboptimal sleep needs to be associated with 
increased cardiometabolic disease risk. Therefore, the aim of this paper is to review the 
association between sleep duration or sleep quality and cardiometabolic disease risk factors 
in both experimental and observational studies. Note that obstructive sleep apnea, a sleep 
disorder associated with cardiometabolic diseases, is beyond the scope of this article (please 
see [20] for a review of this topic). The next step for research would be to explicitly test 
whether sleep partially mediates cardiometabolic disease disparities.
2. Sleep loss and its role in the development of cardiometabolic disorders: 
What do experimental studies tell us?
Sleep is an important and complex physiological process that is critical for maintaining 
metabolic homeostasis. Disturbances in metabolic homeostasis can increase the risk for 
developing cardiometabolic diseases, such as diabetes, obesity and heart diseases. Mounting 
evidence suggests that suboptimal sleep is a possible risk factor in the development of 
cardiometabolic disease. The effects of experimental sleep manipulation, which includes 
sleep deprivation or fragmentation, on cardiometabolic measures will be discussed in the 
following paragraphs. It is important to recognize that these effects of sleep are not isolated 
to any one of these single outcomes. Cardiometabolic diseases often share overlapping and 
intertwined pathways of sleep-regulated metabolic function, and perturbations in any one 
pathway may lead to increased risk of multiple metabolic disorders (see Figure 1). 
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Controlled laboratory studies of sleep restriction and/or sleep fragmentation have shown that 
sleep curtailment under conditions of total sleep deprivation (TSD; continuous wake) or 
partial sleep deprivation (PSD; reduced sleep period) even for a night, impairs metabolic 
function and homeostasis.
2.1 Sleep and Diabetes
2.1.1 Glucose metabolism—In healthy individuals, glucose homeostasis is a tightly 
regulated balance between glucose release into the blood and glucose utilization to maintain 
a plasma glucose level of approximately 5 mmol/L. A decrease in plasma glucose levels 
suppresses the release of insulin by pancreatic β-cells, activates the sympathetic nervous 
system and triggers the release of pancreatic α-cell glucagon, catecholamines, cortisol and 
growth hormone (GH). These changes will collectively inhibit glucose uptake and increase 
hepatic glucose release into the blood. On the other hand, an increase in plasma glucose will 
lead to the stimulation of insulin secretion and suppression of glucagon to restore normal 
glucose levels. One of the key regulatory factors in glucose metabolism is insulin. Insulin 
regulates glucose metabolism through both direct actions (binding to insulin receptors in the 
muscle and adipose tissue to stimulate glucose uptake) and indirect actions (suppression of 
glucose release from the liver and kidney, inhibition of free fatty acid (FFA) release). Insulin 
resistance is the decreased ability of cells to respond to insulin. This generally leads to an 
abnormal increase in pancreatic insulin secretion to regulate plasma glucose uptake. When 
this compensation from the pancreatic β-cells becomes insufficient, it leads to type 2 
diabetes mellitus (T2DM).
Spiegel et al demonstrated a direct effect of sleep restriction on glucose metabolism [21]. In 
this study, glucose tolerance measures were taken after one week of partial sleep deprivation 
of 4 hours in bed per night for 6 nights (sleep-debt) and after 6 nights of 12 hours per night 
in bed (sleep-recovery). A 40% decrease in the rate of glucose clearance (glucose tolerance) 
and a 30% decrease in glucose effectiveness, the ability of glucose to mediate its own 
disposal independent of insulin, were observed during the sleep-debt condition. This was the 
first evidence showing sleep loss can impair glucose metabolism. Subsequent studies further 
corroborated this finding. Acute partial sleep restriction of 4 hours in bed for one night when 
compared with a night of unrestricted sleep showed an increase in endogenous glucose 
production (p=0.017) and a decrease in glucose disposal rate (p=0.009) from a 
hyperinsulinemic clamp assessment indicating a decrease in hepatic and peripheral insulin 
sensitivities [22]. In another study, 2 nights of sleep curtailment to 4 hours in bed per night 
in healthy men reported a significant decrease in insulin sensitivity compared to 2 nights of 
unrestricted sleep [23]. In other studies that enforced partial sleep deprivation (5 hours in 
bed) for one week in men [24] and 4 days of decreasing sleep curtailment (7 hours, 6 hours, 
4 hours, 4 hours on consecutive nights) in women [25] also observed decreased insulin 
sensitivity and glucose tolerance. The chronic effects of sleep loss on alterations in glucose 
metabolism were further demonstrated by a randomized crossover study comparing 5.5 
hours in bed per night for 2 weeks to 8.5 hours in bed per night for 2 weeks in 11 healthy, 
overweight individuals. This sleep restriction period was associated with reduced oral 
glucose tolerance and insulin sensitivity [26]. Quality of sleep also affects insulin sensitivity 
as demonstrated by a study that fragmented sleep across the night [27], and another that 
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suppressed Stage N3 (deep non-REM sleep or slow wave sleep [SWS]) [28]. In both of 
these studies decreased glucose tolerance and insulin sensitivity were observed. A single 
night of SWS or REM suppression was compared to a night of uninterrupted sleep in 16 
healthy men and insulin sensitivity was decreased after SWS-suppression (−15%, p<0.001) 
but not REM suppression [29].
These studies collectively suggest that sleep durations of 6 hours or less across multiple 
consecutive nights and poor sleep quality has profound effects on glucose metabolism and 
homeostasis.
2.1.2 Counter-regulatory molecules—Other counter-regulatory hormones coordinate 
glucose homeostasis and are impacted by sleep curtailment, including glucagon [30] and 
catecholamines [31]. The alterations in the secretory profiles of these molecules may also 
contribute to the changes in glucose regulation observed after sleep restriction. Two 
crossover studies of a single night of total sleep [32] or partial sleep [30] deprivation showed 
decreased basal glucagon levels, however catecholamines levels remained unchanged. In 
another study of partial sleep deprivation, one night of partial sleep deprivation was 
associated with significantly increased catecholamine levels [31]. A similar finding was also 
reported in a crossover study of 14 healthy males during 24-h continuous wakefulness [33]. 
They reported an increase in nocturnal and daytime levels of norepinephrine (p<0.05). 
Another study that included both men and women reported an increase in nocturnal and 24-h 
epinephrine (p<0.05) and nocturnal norepinephrine (p<0.05) during 2 weeks of 4.5 hours in 
bed per night compared with 8.5 hours in bed per night [26]. Three days of 4 hours in bed 
per night compared to 9 hours in bed per night for 3 days in adolescent boys resulted in an 
increase in fasting insulin (+59%, p=0.001), fasting C-peptide (+24%, p<0.001) and post-
prandial C-peptide (+11%, p=0.018), in addition to a 24% decrease in 24-hour epinephrine 
levels (p=0.013) [34]. The combination of elevated insulin and C-peptide levels and 
unchanged glucose and glucagon levels indicate a reduced sensitivity to insulin. These 
studies point to a suppressive action of sleep loss on pancreatic α-cell glucagon secretion 
irrespective of glycemic level. The pancreatic glucose regulation could be partly under the 
control of the autonomous nervous system.
2.1.3 Adipokines—In addition to skeletal muscle and liver, another important insulin-
sensitive peripheral tissue is the adipose tissue, which is comprised mainly of adipocytes, 
fibroblasts, immune cells and other cell types. It secretes various peptides and proteins 
collectively called adipokines, and include leptin, adiponectin, omentin, resistin, TNF-α and 
IL-6. The white adipose tissue is not only an energy-storage depot; it is also an endocrine 
regulator of energy homeostasis. Acute sleep restriction of 4.5 hours in bed per night for 4 
days was compared to 8.5 hours in bed per night for 4 days in a randomized cross-over study 
[35]. The phosphorylation of Akt is a crucial early step in insulin signaling in the adipocytes, 
and the effect of increasing doses of insulin on the phosphorylation of Akt was reduced by 
30% (p=0.01) after acute sleep deprivation, which indicates decreased insulin sensitivity in 
the adipose tissue. There was also a parallel reduction in total body insulin sensitivity 
(p=0.02). The actions of insulin through the Akt pathway in adipose tissue include leptin 
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secretion and fat metabolism and therefore alterations in the insulin sensitivity of the adipose 
tissue could have important metabolic consequences.
One of the most studied adipokines in relation to sleep duration is leptin, which is produced 
by the adipocytes in proportion to the mass of the adipose tissue. Leptin signals satiety 
through its interactions with the appetite-regulating centers in the brain; hence it is called the 
satiety hormone. Leptin is regulated by insulin through glucose metabolism (i.e. by food 
intake) and it also has a diurnal rhythm that peaks at the nocturnal sleep phase and declines 
in the morning a few hours after a rise in levels of another adipokine called adiponectin [36, 
37]. Continuous total sleep deprivation for 88 hours in healthy men (body mass index (BMI) 
range: 20–34.5 kg/m2) decreased the nocturnal amplitude of leptin (p<0.001) [38]. 
Similarly, 4 hours in bed per night for 6 days significantly decreased leptin’s amplitude by 
20% when compared with 12 hours in bed per night for 6 nights in 11 lean men [39]. Partial 
sleep deprivation of 4 hours in bed for 2 days also decreased leptin levels (−18%, p=0.04) in 
12 healthy men (BMI: 23.6 ±2.0 kg/m2) [40]. The effects of sleep restriction on leptin levels 
in subsequent studies have been mixed, with some studies reporting an increase in leptin 
[25, 41–45] while others reported no significant difference [33, 46–51] after sleep 
restriction. Among the studies that did find an increase in leptin levels, one measured the 
energy balance of the subjects and found energy balance to be positive during sleep loss in 
comparison to after habitual sleep [25]. Leptin increased in parallel with increase in energy 
intake and energy expenditure [25], while other studies either reported no significant 
differences in energy intake [42, 45, 52] or did not evaluate energy expenditure [44]. Among 
studies that reported no significant difference in leptin, some did not assess energy intake or 
controlled calorie intake [33, 46, 51] while others reported increase in calorie intake without 
any changes in energy expenditure [47, 49, 50]. Finally, a recent study of sleep restriction 
observed decreased leptin levels, consistent with the Spiegel et al study described above. In 
this study, 19 healthy men were sleep restricted by 1.5 hours each night for 3 weeks [53]. In 
the sleep-restricted group, morning leptin levels after three weeks of sleep restriction were 
reduced (p=0.023) compared to baseline. The subjects were allowed to eat ad libitum but no 
documentation of calorie intake during those 3 weeks was reported. Interpreting the 
discrepant results regarding sleep restriction and leptin levels is further complicated by the 
dynamic relationship between leptin, food intake and body fat changes, and these three 
components are not always measured and/or controlled.
Adiponectin is another adipocyte-derived hormone that has been known to have anti-
inflammatory properties. Decreased plasma levels of adiponectin have been associated with 
increased insulin resistance. Like leptin, adiponectin has an internal circadian rhythm that 
peaks late in the morning and decreases during nocturnal sleep [37]. In one study 74 healthy 
adults were allowed 4 hours in bed per night for 5 days (sleep restriction) after 2 nights of 10 
hours in bed (baseline) [52]. A decrease in plasma adiponectin levels after sleep restriction 
compared to baseline was observed among Caucasian women (p = 0.028), but an increase in 
adiponectin after sleep restriction compared to baseline was observed among African 
American women (p = 0.006) despite similar adiponectin levels at baseline in both racial 
groups. No significant alterations of adiponectin were observed among men [52]. An 
increase in leptin under conditions of leptin resistance and a decrease in adiponectin 
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contribute to the pathogenesis of insulin resistance and diabetes in overweight or obese 
individuals. Other adipokines that are altered under controlled conditions of sleep loss are 
TNF-α and IL-6, which will be discussed below in section 2.4.2.
In conclusion, sleep loss has a deleterious effect on insulin sensitivity and overall glucose 
homeostasis through alterations in several key metabolic hormones, including insulin, leptin 
and other adipokines.
2.2 Sleep and Obesity
Experimental studies of sleep restriction have demonstrated an effect of short sleep on 
markers of positive energy balance such as decreased energy expenditure (EE), increased 
feelings of hunger and appetite, increased food intake and changes in appetite regulating 
hormones. The effects of acute sleep curtailment on energy homeostasis could lead to 
weight gain overtime if sleep loss is extended for longer periods.
Studies have examined the effects of sleep restriction on hunger and food intake. For 
example, a single night of TSD or PSD (4.5 hours in bed/night) leads to a significant 
increase in hunger [51]. Partial sleep restriction of 4 hours in bed per night for 2 consecutive 
days induced an increase in hunger and appetite (+23–24%, p<0.01) especially for foods 
with high carbohydrate content such as sweets and salty snacks (p<0.02) [40]. In 14 healthy 
women (BMI: 20.0–36.6 kg/m2), 4 nights of consecutively increasing sleep curtailment (7 h, 
6 h, 6 h and 4 h sleep/night) with an ad libitum diet had a profound effect on total energy 
intake (+20%, p<0.05) with no changes in energy expenditure [25]. A single night of 4 hours 
in bed, when compared to 8 hours in bed, increased total calorie intake by 22% (p<0.01) 
[54]. This increase in food consumption was mostly during breakfast and dinner, particularly 
under free-living conditions, and was preceded by greater sensation of hunger. A 
significantly higher preference for fatty foods was also noted on the day after sleep 
restriction, particularly at dinner. In another study, participants were restricted to two-thirds 
of their habitual sleep time for 8 days and their caloric consumption was measured [47]. The 
wake time for all participants was constant and ad libitum food intake was allowed. Under 
these conditions, caloric intake increased by 677 kcal/d (p=0.014) in the sleep deprived 
state. Mimicking a typical work-week, 31 participants in another study were allowed to 
sleep for 4 hours per night for 5 days and a control group of 6 participants were allowed 10 
hours in bed [55]. Sleep-restricted subjects consumed more calories (+30% of daily caloric 
requirement, p=0.003) during days with restricted bedtime compared with control subjects 
during corresponding days. In a study that limited time in bed to 5.5 hours in bed per night 
for 2 weeks with ad libitum access to food and snacks did not observe changes in caloric 
intake during meals or energy expenditure, but calories from snacks increased (p <0.04) 
[26]. In another study, 15 men and 15 women were restricted to 4 hours in bed per night for 
5 days after 9 hours in bed per night for 5 days [56]. The diet on the first 4 days was 
controlled, while ad libitum food intake was allowed on the last day. Participants consumed 
more energy on day 5 after short sleep (2813.6 ± 593.0 kcal) than after 9 hours in bed 
(2517.7 ± 593.0 kcal; p = 0.023). This effect was mostly due to increased consumption of fat 
(p =0.01), notably saturated fat (p = 0.038) after short sleep. This study also observed 
differences in energy intake between men and women. Women had a 15.3% increase in 
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energy intake after short sleep relative to habitual sleep (p = 0.07), while men had a 9.2% 
increase (p = 0.14). The increase in the consumption of fatty foods also varied between 
women (+39%, p=0.007) and men (+10.3%, p=0.32). When comparing these studies, the 
different effects on food intake could be attributed to differences in study design such as 
availability of types of food, snacks, and participant characteristics such as age, gender and 
BMI. These studies bolster the notion that sleep loss could lead to increased appetite, 
particularly for unhealthy foods, could promote weight gain.
Specific sleep stages may be related to hunger and appetite. Specifically, inverse 
associations between REM sleep duration and hunger (p<0.031) and between stage 2 sleep 
and appetite for sweet (p<0.015) and salty (p<0.046) foods were detected in one study [57]. 
This study also observed that Stage 2 sleep percentage was inversely related to energy 
consumed (p<0.024) and the percentages of Stage 2 sleep (p<0.005), SWS (p<0.008), and 
REM sleep (p<0.048) were inversely related to fat intake, while SWS (p<0.040) and REM 
sleep durations (p<0.050) were inversely related to carbohydrate intake. Thus, more REM 
and more SWS were associated with less fat and carbohydrate intake. In another study that 
used PSG, a night of fragmented sleep in male subjects resulted in a decrease in REM 
(p<0.05) and an increase in the post-dinner desire-to-eat ratings (p<0.05) the following day 
[46]. Thus, specific sleep stages, such as REM and SWS, may be particularly important in 
appetite regulation.
A few studies noted differences in energy expenditure (EE) under conditions of sleep 
deprivation. In one study of 5 hours in bed per night for 5 days, showed an increase in 24-h 
EE (+5%, p<0.01) when compared with 9 hours in bed per night for 5 days [41]. A parallel 
increase in food intake (+6%, p<0.05) was observed. Post-dinner snacking increased with a 
greater preference for carbohydrates. This may be attributed to the increased energy required 
to stay awake during periods of wakefulness and ad libitum availability of food. The study 
participants had an overall positive energy balance with an average yet statistically 
insignificant increase in weight gain in the 5-h per night sleep condition. Other studies have 
shown a decrease in EE following sleep loss. In 14 normal-weight men in the morning after 
24-h of continuous wakefulness both resting and postprandial EE were assessed along with 
hunger ratings before the standardized breakfast. The resting (−5%, p<0.05) and 
postprandial (−20%, p<0.001) EE were significantly reduced after one night of total sleep 
deprivation with a significant increase in hunger ratings while no changes in ad libitum food 
intake in the afternoon was observed [33]. One night of TSD in 7 healthy participants 
increased EE by 32% during the night of TSD and then decreased by 4% during the 
recovery night when compared to baseline [58]. Some studies also showed that sleep 
restriction decreased physical activity, which may contribute to lower EE during sleep debt. 
In 15 healthy men spontaneous physical activity was recorded by accelerometer during a 15-
h daytime period after 2 nights of restricted bedtime (4.5 hours in bed per night) [49]. Sleep 
deprivation significantly decreased physical activity (p=0.008) and also shifted the physical 
activity towards lower intensity activity (p<0.05) without any changes in energy intake. 
Another study of a single night of sleep restricted to 4 hours in bed per night resulted in a 
22% increase in caloric intake (p<0.01) with a significant increase in physical activity 
recorded by an actimeter despite an increase in sleepiness [54]. The latter study allowed ad 
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libitum food intake and that may be reflected in the increased calorie intake with increased 
physical activity. The data summarized above suggests that increased food intake during 
insufficient sleep is a physiological adaptation to provide energy needed to sustain 
additional wakefulness; yet when food is easily accessible, intake surpasses need. The 
increase in appetite and food intake coinciding with decreases in physical activity and 
energy expenditure under sleep-deprived conditions could result in overeating.
In addition to the homeostatic system, the hedonic system also plays an important role in 
regulating food intake. After one night of TSD, 16 healthy normal-weight men choose larger 
food portions (+14%, p=0.02) in correspondence with increased hunger status [59]. The 
portions of snacks consumed after breakfast also increased (+16%, p=0.02). TSD [60] and 
PSD [61] lead to greater stimulation of brain regions in response to hedonic food stimuli. 
The overall neuronal activity measured by fMRI in response to food stimuli was greater 
after sleep restriction than habitual sleep. The areas of brain with increased neuronal activity 
after sleep deprivation were associated with reward centers. Another study showed sleep 
loss decreases activity in the appetite evaluation regions within human frontal cortex and 
insula cortex during food desirability choices combined with an increase or amplification of 
activity within the amygdala promoting a desire for high-calorie foods [62].
Sleep restriction is also known to alter the hormonal profile of appetite regulating hormones: 
anorexigenic leptin (discussed previously) and orexigenic ghrelin. While ghrelin and leptin 
levels remain unchanged in some studies [46, 47, 49, 50], a few others have shown 
significant changes after sleep deprivation. A randomized crossover study of 16 healthy 
normal-weight men resulted in an increase in hunger ratings parallel to an increase in 
morning plasma ghrelin levels (+13%, p=0.04) after one night of TSD when compared to 8 
hours in bed sleep opportunity [59]. A similar study with 14 men also showed elevations in 
morning ghrelin levels (p<0.02) following the night after TSD [33]. In yet another study 
with 9 healthy normal-weight men plasma ghrelin levels were 22% higher after total SD 
than after 7 hours of sleep (p <0.05) [51]. Feelings of hunger were elevated, whereas 
morning leptin concentrations remained unaffected. In a randomized crossover study of 12 
healthy normal-weight men, 2 consecutive nights of PSD (4 hours in bed) was compared 
with 2 consecutive nights of 10 hours in bed [40]. Ghrelin levels were elevated (+28%, p 
<0.04), along with an increase in subjective hunger and appetite (p<0.01). In another study 
of 27 normal-weight men and women, 3 nights of 4 hours in bed (PSD) was compared with 
9 hours in bed under conditions of controlled calorie intake [48]. Total morning ghrelin 
increased (p<0.05) in men but not in women. On the contrary, in a study of 16 healthy 
normal-weight adults (8 men and 8 women), 24-h ghrelin levels decreased after a night of 
PSD (5 hours in bed) in comparison to baseline (−30%, p<0.001), while the 24-h leptin 
levels increased (+22%, p<0.05) under the same conditions [41]. Although the changes in 
hormone levels promoted satiety and reduced hunger, there was a significant increase in 
overall food intake promoting overeating in this study. Thus, the association between ghrelin 
and sleep loss is not consistent, which may be due to duration and severity of sleep 
restriction as well as to the complex association between food intake and regulation of this 
hormone.
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If sleep loss increases appetite and subsequently food intake without a compensatory and 
equivalent increase in energy expenditure, then sleep loss could increase risk of weight gain 
and obesity.
2.3 Sleep and Cardiovascular diseases
2.3.1 Blood pressure—Circulation of blood by the cardiovascular system is partially 
mediated through the regulation of blood pressure (BP). Baroreflex modulated by behavioral 
and physiological changes contributes to control of arterial blood pressure through the 
autonomous nervous system and baroreceptors. In a normotensive person the BP circadian 
rhythm is characterized by a steep nocturnal/sleep decrease called BP dipping and a rise in 
the wake-associated elevations of BP. Non-dipping in BP is associated with CVD risk [63] 
and has been associated with poor sleep [64]. Increased BP during sleep deprivation could 
be due to a combination of factors such as increased sympathetic outflow to the heart or 
periphery, decreased baroreflex sensitivity and a resetting of the baroreflex set-point to a 
higher level.
After a night of total sleep deprivation in 8 healthy men and women, the systolic BP (SBP) 
(p=0.002) and diastolic BP (DBP) (p=0.05) were significantly higher than after a night of 
regular sleep. However, the morning plasma catecholamines and heart rate remain 
unchanged [65]. In another study of 6 healthy men, TSD increased diastolic BP (p=0.02) and 
increased arterial baroreflex set-point by 12 mm Hg (p<0.05) [66]. No changes in morning 
plasma catecholamines, including epinephrine and norepinephrine, dopamine, or cortisol 
were recorded. These two studies attribute the effects of sleep deprivation on baroreflex to 
changes in peripheral and central mechanisms but did not observe an increase in their 
measures of sympathetic nervous activity. This could be due to the subjects resting in a 
supine position throughout the study [67]. This scenario is unlikely to occur in the real 
world, as it may be difficult to stay awake recumbently when sleep pressure is high.
A single night of sleep restriction in normotensive subjects from 8 hours in bed to 5 hours in 
bed was associated with an increase in the morning to mid-afternoon SBP and heart rate 
(p<0.05) [68]. When the PSD duration was increased to 4 hours in bed for 6 consecutive 
nights, a significant decrease in heart rate variability was observed (p<0.02), which indicates 
elevated sympathovagal balance [21]. Another study found no significant differences in 
SBP, DBP, or mean arterial pressure (MAP) after 36 hours of continuous sleep deprivation 
in 18 subjects seated in an upright position while the measurements were taken, but arterial 
baroreflex sensitivity significantly decreased [69]. This study also observed a significant 
increase in sympathetic modulation of BP variability and reduction in parasympathetic 
modulation of heart rate variability, which suggests increased sympathetic nervous activity. 
In summary, the above studies demonstrate the effects of acute sleep loss on HRV, BP and 
arterial baroreflex sensitivity and a prolonged effect of sleep loss on these cardiac measures 
could increase the risk for heart diseases.
2.3.2 Endothelial dysfunction—The endothelium, a thin layer of cells that forms the 
inner surface of blood vessels, controls vascular tone, inflammatory response and 
coagulation [70]. Endothelial function is clinically assessed as the degree of impaired 
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vasodilation measured in arterial and venous circulation by changes in vessel diameter [71, 
72]. Impairment of endothelial function is a mechanism in the development of CVD [73] 
and also an independent predictor of CVD risk [74]. In a randomized controlled study of 15 
healthy lean participants (10 men, 5 women), partial sleep deprivation (two thirds of regular 
sleep duration) for 8 days showed a significant impairment in arterial endothelial function 
(−4.4%, p<0.01) when compared to the control group [75]. In another randomized crossover 
study of 18 healthy male participants, partial sleep deprivation (<5 hours) for 5 days was 
compared to regular sleep (>7 hours) and a significant reduction in venous endothelial 
function was observed [76]. Similarly, acute total sleep deprivation (TSD) also altered 
endothelial-dependent arterial [77] and microvascular activities [78] in healthy participants. 
Thus, experimental sleep loss appears to impair endothelial function.
Sleep debt impacts many of the risk factors for CVD, including increased blood pressure, 
insulin resistance, obesity, unhealthy diet, and lower physical activity as suggested by the 
controlled sleep deprivation studies discussed previously. In addition to these risk factors, 
cardiometabolic diseases, which are known to be inflammation-associated pathological 
states, can be exacerbated by the activation of stress and immune systems during prolonged 
cumulative sleep restriction.
2.4 Potential Mechanisms that relate sleep to cardiometabolic disease risk
2.4.1 Stress response—Several studies have shown an activation of the hypothalamic-
pituitary-adrenal (HPA) stress axis in response to sleep restriction. The HPA axis is the 
principal mediator of the neuroendocrine stress system and seems to play a central role in 
sleep debt induced metabolic impairment. Activation of HPA axis initiates hypothalamic 
secretion of corticotropin-releasing hormone (CRH) leading to the secretion of 
glucocorticoids (cortisol) by the adrenal cortex. Cortisol inhibits the activation of the HPA 
axis through a negative feedback loop to the hypothalamus and pituitary. The circadian 
rhythm of the HPA axis is regulated via the suprachiasmatic nuclei (central pacemaker) in 
the brain. Cortisol rhythmicity is a critical regulatory component of the sleep/wake cycle. In 
a healthy person with sufficient nocturnal sleep cortisol levels begin to increase toward the 
end of their sleep period resulting in a morning surge in cortisol levels that peaks shortly 
after awakening. After this peak, the negative feedback mechanism begins to suppress the 
HPA axis, leading ultimately to a long quiescent period of low cortisol levels reaching its 
nadir 1–2 hours around sleep onset.
Total sleep deprivation of more than 24 hours [79–81] or partial deprivation of 3–4 hours in 
bed each night for 1–3 days [34, 44, 82] showed no significant change in morning cortisol 
levels after sleep deprivation. The same trend was observed for levels of plasma 
adrenocorticotropic hormone (ACTH), which is produced by the pituitary in response to 
CRH [83]. In other studies of partial sleep deprivation (3–4 hours in bed per night) where 
bedtimes were either delayed or wake times were advanced, decreased morning cortisol 
levels were observed in men [84, 85] and women [45]. REM sleep has been shown to be 
positively correlated with morning cortisol levels [86] but inversely associated with 
afternoon cortisol levels [87] and could partly explain decreased morning cortisol levels 
after sleep restriction. It is possible that sleep restriction causes a shift in the time of morning 
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cortisol rise and/or the prolonged wake time activates the HPA axis through the night 
decreasing the amplitude of morning cortisol peak. This in addition to the lack of repeated 
blood sampling before and after morning wake time suggests the possibility that the actual 
peak of cortisol may have been missed. Another possibility is the rate at which the morning 
cortisol levels decrease following its peak is slower after a night of sleep restriction resulting 
in elevated evening cortisol levels. This was shown in the study of acute sleep restriction (3 
hours in bed for one night) [45] and prolonged sleep restriction (4 hours in bed per night for 
5 days) [23, 42]. In the first study, a significant reduction in morning cortisol (p=0.02) and 
an elevation in evening cortisol (p=0.04) as a result of slower decline of daytime cortisol 
(p=0.04) was observed after sleep restriction [42, 45]. In the second study, an increase in 
cortisol (p=0.002) but not ACTH levels was observed after 5 days of sleep deprivation 
[42Schmid, 2011 #6886]. Cortisol was 15.5% higher after sleep restriction but decreased 
during the day due its internal rhythmicity. An increase in evening cortisol levels was a 
result of a slower decline of daytime cortisol. The elevation of evening cortisol was recorded 
in other studies of sleep restriction as well [85, 88, 89]. [42]Cortisol levels also increased 
after sleep fragmentation when compared with non-fragmented sleep (p<0.05) [46]. This 
difference is attributed to a lower morning rise in cortisol and higher evening cortisol level 
[46]. A controlled study that simulated habitual sleep patterns of a typical week included 5 
days of sleep restriction (work week) followed by 2 days of extended sleep opportunity 
(weekends). No changes in 24-h cortisol was observed when comparing sleep restriction to 
baseline, however a decrease in 24-h cortisol levels during sleep extension (p<0.05) was 
observed. [90]. In summary, cortisol levels appear to increase as a result of sleep loss and 
these elevated levels could exacerbate sleep disturbances. Higher cortisol levels are 
associated with insulin resistance hours [91, 92] and therefore could be one mechanism 
through which sleep loss impairs glucose metabolism. HPA axis activation can also regulate 
immune cell traffic [93] and provides another possible link between sleep and chronic-
inflammation based diseases.
An additional or alternative pathway linking sleep, stress and glucose metabolism involves 
gene expression. Partial sleep restriction for 4 hours in bed per night for 5–7 days activated 
several gene pathways, notably those that were involved in the stress response and 
apoptosis, as measured by gene microarray [94, 95]. A similar differential gene expression 
was observed after a single day of prolonged wakefulness [96]. These studies elucidate the 
possibility that a mechanism alternative to cortisol-HPA-stress axis may be activated. Sleep 
deprivation showed differential expression of stress-related genes particularly those related 
to endoplasmic reticulum (ER) stress. ER stress can lead to protein misfoldings that activate 
the unfolded protein response (UPR) pathway. The cell produces heat shock proteins (HSP) 
to counter the perturbations caused by ER stress, but when it fails to check the UPR 
stimulation, it triggers cell apoptosis. For example, activation of the ER stress pathway in 
macrophages could lead to apoptosis, which is detrimental in atherosclerotic lesions.
2.4.2 Sleep and Immune system—Chronic inflammation, a risk factor for CVD, is 
caused by disruption to immune system homeostasis. The immune cells follow the 24 hour 
biological rhythm that is regulated by the central clock, and sleep is partly regulated by 
proinflammatory cytokines. Some of the key sleep-associated inflammatory measures 
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include cytokines such as TNF-α, IL-1, IL-2, IL-6 and IL-10 and immune cells such as 
neutrophils, monocytes, lymphocytes. The mechanism of activation and regulation of this 
neuroendocrine-immune axis is not entirely known. Sleep deprivation disturbs the circadian 
rhythm of the immune cells leading to disruptions of the physiological rhythms that could 
lead to metabolic and endocrine consequences. It has been shown that white blood cells 
(WBCs) such as neutrophils and natural killer (NK) cells peak during the light phase of the 
sleep/wake cycle and reach their nadir during the dark cycle, while the circulating 
monocytes, T and B lymphocytes peak during the early stages of nocturnal sleep and 
decrease during the day [97]. A circadian rhythm in cytokines has also been observed. TNF-
α, IL-1, IL-2, IL-6 and IL-12 (proinflammatory) reach their peaks during the sleep phase 
while IL-10 (anti-inflammatory) reaches its maximum levels proceeding wake initiation.
Total sleep deprivation (TSD) of 40 hours or more in humans alters both the cellular and 
cytokine patterns of immune cells. A delay in the rhythm of lymphocytes and monocytes by 
3 to 6 hours was observed in TSD compared to normal sleep. Lymphocytes, monocytes and 
natural killer (NK) cells were significantly higher during the night of wakefulness and 
remained high the following day when compared to baseline [81, 98]. Two nights of TSD 
increased neutrophils and leukocytes but the levels returned to baseline after sleep recovery 
[99]. On the contrary, the leukocyte numbers measured in the morning after >40h of TSD 
showed a decrease in NK cell counts (p=0.001) and an increase in monocytes (p=0.017) 
[81]. Partial sleep deprivation (PSD) is a better representation of habitual sleep loss in the 
population than TSD. Studies that followed a PSD sleep protocol showed variable results in 
leukocytes count as well. An increase in WBC count (p=0.03) and neutrophils (p=0.01) was 
observed the morning after 3 nights of PSD to 4 hours in bed per night [100]. No changes in 
monocytes, lymphocytes and CRP were reported. The increase in leukocyte numbers 
persisted even after a night of sleep recovery following acute partial sleep loss [101]. Further 
analysis showed a significant increase in neutrophil populations. Another study reported a 
decline in NK cell activity by 30% (p<0.01) after a night of PSD (4 hours per night) towards 
the later part of sleep [102]. This was restored after sleep recovery the following night. 
Partial sleep deprivation during the early part of sleep for one night showed no changes in 
WBC count across baseline, PSD and recovery nights [103]. However, granulocyte numbers 
significantly decreased while lymphocyte numbers increased the morning after PSD. 
Recovery night restored the immune cell numbers to baseline values. Simultaneous decrease 
in NK cell activity (p<0.05) was observed after accounting for fluctuations in NK cell count 
between baseline and PSD suggesting an impairment in its activity independent of 
decrements in the number of NK cells. An inhibitory effect of sleep restriction on NK cell 
count and activity were observed. In parallel, a significant reduction in T helper cell IL-2 (an 
activator of NK cells) production was observed. This reduction in NK cell activity persisted 
even after a night of recovery sleep. When T lymphocytes collected after sleep restriction 
were incubated with monocytes after baseline sleep, a decrease in IL-2 production signified 
the effect of partial sleep deprivation on T cell function. A night of TSD elevated neutrophil 
counts and altered subpopulations of circulating neutrophils the following morning [104]. 
An increase in immature cells and CD11b surface marker was observed. The elevation of 
CD11b and CD35 on neutrophils is observed in chronic inflammatory diseases like asthma. 
This suggests nocturnal wakefulness may promote a pro-inflammatory state of circulating 
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immune cells. The effect of sleep deprivation on WBC numbers have been mixed across 
studies and this variation could be explained by differences in blood sampling frequency, 
time of day and sample heterogeneity. Changes in immune cell numbers after SD, for the 
most part, returned to baseline levels after recovery sleep. This could suggest an alteration in 
their redistribution between the lymphoid organs and peripheral tissue. This could 
potentially play a role if sleep activates inflammation in peripheral tissues like adipose tissue 
and thereby modulating cellular insulin sensitivity.
Effects of sleep loss on cytokine gene and protein expression have also been recorded. The 
two most commonly assessed cytokines are IL-6 and TNF-α. These proinflammatory 
cytokines are primarily monocyte derived and are elevated during slow wave sleep and 
reach their nadir in the morning [105]. After a night of TSD, mean daytime IL-6 values were 
significantly higher (p<0.05) than baseline and a nighttime undersecretion (p<0.05) was 
reported [106]. When compared with a night of continuous wakefulness, sleep elucidated an 
increase in the concentrations of soluble IL-6 receptors (sIL-6R) but not membrane-bound 
IL-6R which negatively regulate IL-6 trans-signaling [107]. No changes in IL-6 producing 
monocytes were observed. TSD was associated with an increase in proinflammatory IL-1β 
[108]; however data on IL-6 have been mixed. Continuous wakefulness resulted in the 
increase in IL-6 [88, 109, 110], decrease in IL-6 [111] or no measurable changes [97, 108]. 
This could in part relate to IL-6 cytokine’s dual pro- and anti- inflammatory roles. 
Continuous wakefulness of 40 hours significantly increased TNF-α (p<0.01) but not its 
receptor, TNFR1 [112]. No changes in IL-6 and CRP levels were documented.
PSD for one night (4 hours in bed) showed a significant increase in nocturnal IL-6 levels 
compared to baseline [113]. Blood was sampled during the nocturnal sleep period. However 
daytime IL-6 levels after PSD was not measured. Another study of acute partial restriction 
of REM sleep across 4 days showed no changes in cytokines IL-1β, IL-2, IL-4, IL-6, IL-10, 
TNF-α and IFN-γ but a significant increase in T lymphocytes and IgA. However, another 
study that included a week of PSD from 8 hours in bed to 6 hours in bed for 7 nights showed 
elevated levels of 24-h IL-6 (p<0.01) and TNF-α (p<0.05), indicating a pro-inflammatory 
shift [114]. A similar increase in proinflammatory cytokines IL-1β (137%, p<0.05), IL-6 
(163%, p<0.05) and IL-17 (138%, p<0.05) was observed in stimulated peripheral blood 
mononuclear cells (PBMC) collected after 5 nights of PSD to 4 hours in bed [115]. A 
possible difference in results could be attributed to limits in detection of low concentrations 
of plasma cytokine levels owing to their short half-life and sensitivity of assay used for its 
detection. Moreover, frequency of sampling may vary; some studies include a single 
morning sample and local inflammation caused by repeated blood sampling via catheter 
insertion could also confound the results [116]. Stimulation of PBMC in vitro, could detect 
low-grade inflammation that may not be captured in plasma samples.
Recently analysis of the transcriptome of blood cells after sleep deprivation has shed light 
on the differential expression of several genes; a common thread being alteration of immune 
pathways. Whole genome microarrays complemented with pathway and transcription factor 
analysis of blood samples comparing experimentally induced PSD of 4 hours in bed per 
night for 5 days to baseline and post-recovery periods revealed that 33% of the 25 most up-
regulated genes were related to immune function including IL-8 biosynthesis regulation 
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(p<0.001), lymphocyte activation (p<0.02) and NF-kB signaling (p< 0.005) besides several 
genes related to stress signaling [94]. Among the 25 most down-regulated genes 19 were 
associated with immune system including NK cell function. Cumulative sleep restriction 
(SR) resulted in an increase in IL-8 production along with activation of TLRs, NF-kB and 
AP-1. These pathways point towards the activation of pro-inflammatory cascade through the 
innate immune system. This study also showed a shift towards Th2 cell type while the total 
number of T cells remained constant. This, along with the gene expression data, suggests 
acute SR activates the innate and adaptive immune systems. In addition, one night of TSD 
significantly decreased the number of pre-mDC producing IL-12, a main inducer of Th1 
response [117]. Compared to a night of sustained wakefulness, sleep suppressed IL-4 
producing Th2 cells [118]. The Th1/Th2 balance measured by IFN-γ/IL-4 producing T cells 
was enhanced by SWS. During the REM phase of sleep, the Th balance reversed. But the 
ratio of Th2/Th1 was lower (p<0.01) during sleep than wakefulness.
Natural regulatory T cells (nTreg) are key regulators of adaptive immune responses that are 
regulated by IL-2 production. They are known to attenuate activated immune responses and 
control systemic immune homeostasis. Following one night of TSD, nTregs known to 
exhibit its highest suppressive activity during sleep, was diminished [119]. To put it in 
context, the increase in pro-inflammatory cytokines during sleep will consequently lead to 
subsequent increases in the suppressive activity of nTregs to maintain immune homeostasis. 
In this study, the levels of IL-2 and T cell proliferation were sleep-independent; however the 
same was not true for nTreg activity. A diminished nTreg suppressive activity rhythm might 
be a factor in the aggravation of the immune system post sleep deprivation. PSD during 
early part of the sleep cycle showed an increase in monocytic IL-6 and TNF-α when 
compared to uninterrupted sleep [120]. An increase in mRNA transcripts of IL-6 and TNF-α 
genes were also observed. Bioinformatic analysis suggested the inflammatory response was 
mediated by NF-kB signaling pathway. A significant increase in IL-8 and IL-1β gene 
transcripts was also observed. The data from the gene array was limited by sample size 
(n=5). In the morning after a night of PSD to 4 hours in bed, the activation of NF-kB was 
greater than baseline or sleep recovery mornings [121]. Effects of acute SR on blood 
transcriptome was accessed at time points distributed across the day following 1 week of 
<6h or 8.5 h of sleep each night [95]. Loss of circadian rhythmicity of genes associated with 
peripheral circadian clocks, oxidative stress, inflammation and metabolism were observed 
after acute SR. Another study collected blood samples the morning after normal sleep, after 
48 hours of prolonged wakefulness and after 12 hours of recovery sleep to study the changes 
in blood transcriptome [96]. Differentially expressed genes were identified to represent NK 
cell signaling, endoplasmic reticulum stress, oxidative phosphorylation, mTOR signaling, 
representing a shift towards inflammatory stress response.
In conclusion, sleep loss alters the immune homeostasis and tilts the scales towards 
proinflammation. Even if recovery sleep has been shown to restore the immune balance, 
chronic sleep deprivation for weeks, months and even years, could potentially activate a 
state of chronic low-grade inflammation that could cause metabolic distress.
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3. Habitual sleep and the development of cardiometabolic disorders: What 
do observational studies tell us?
Experimental studies conducted in the controlled environment of the laboratory provide 
detailed information about physiological changes associated with sleep restriction or 
impairments in sleep quality. These studies, however, are brief, lasting only a few weeks. 
Chronic conditions like obesity, diabetes and CVD develop over longer periods of time and 
therefore we need to understand whether habitual sleep patterns are also associated with 
chronic disease risk. Observational, epidemiologic studies can shed some light in this area. It 
is important to keep in mind while interpreting the results from these studies that many of 
these studies had to rely on subjective estimates of sleep duration or sleep quality. Self-
reported sleep duration has been only moderately associated with objectively-estimated 
sleep duration [122, 123]. Nonetheless, numerous studies have observed consistent 
associations using subjective sleep assessments that support the findings of the laboratory 
studies; sleep deficiency appears to be associated with cardiometabolic disease.
3.1 Habitual Sleep and Obesity or BMI
A multitude of observational studies have examined the association between sleep and 
obesity or BMI. Over 60 published articles have reported significant cross-sectional 
associations between short sleep duration (generally <6 hours per night) and increased 
prevalence of obesity or higher BMI (see [124–126] for reviews). These associations have 
been observed in both adults and children and from a variety of countries, including the US 
and countries in Europe and Asia. Many of these studies also observed higher mean BMI 
associated with longer sleep durations (generally >8 hours per night), indicating a U-shaped 
association between self-reported sleep duration and BMI where both short and long 
sleepers have higher average BMI. In addition to sleep duration, worse subjective sleep 
quality has also been associated with higher BMI [127, 128]. One meta-analyses of data 
from many of these cross-sectional studies found that short sleep duration (<5 hours per 
night) significantly predicted prevalent obesity in adults (pooled odds ratio [OR] was 1.55, 
95% confidence interval [CI]: 1.43–1.68) [129]. Thus, most published studies have reported 
a significant cross-sectional association between inadequate sleep (too short or too long) and 
higher BMI or the presence of obesity. One important limitation of these studies is that that 
sleep was self-reported. A few studies have examined objectively-estimated sleep duration. 
For example, a study in the US that collected at least 3 days of wrist actigraphy in over 600 
middle-aged adults found that shorter average sleep duration was associated with higher 
average BMI in cross-sectional analysis [130]. A study in Brazil also collected actigraphy 
data for at least 3 days and recorded one night of PSG in 1,074 adults and found that obese 
and overweight subjects had shorter sleep durations based on actigraphy and PSG and less 
slow-wave sleep (SWS) and REM sleep, although these comparisons were unadjusted [131]. 
A study of over 2,700 older men (≥65 years) in the U.S. recorded one night of PSG and 
found that those with the lowest percentage of SWS had the highest mean BMI and largest 
mean waist circumference, but they did not find an association between SWS and percent 
body fat [132]. Thus, there is some evidence for a cross-sectional association between 
objectively characterized sleep and body size. Of course, another important limitation of 
these studies is that they are cross-sectional and therefore causal direction cannot be 
Rangaraj and Knutson Page 15
Sleep Med. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
inferred. Indeed, the association between sleep and BMI could be bidirectional. It is well-
known that obesity is a major risk factor for obstructive sleep apnea, a sleep disorder that is 
associated with increased risk of cardiometabolic diseases (see [20] and [133] for reviews on 
OSA).
Some prospective studies examined sleep and change in body size measures in adults (see 
Table 1 for details on these studies). Four of these studies did not find a statistically 
significant association between sleep duration and change in body size [130, 134–136]. 
Some studies reported a significant association between shorter sleep and weight gain or 
increased BMI among adult men and/or women [137–145] and sleep disturbances and 
increased weight gain in women [146]. Two studies observed associations between longer 
sleep durations and increased weight gain [141, 142] and in a weight loss study that 
compared an exercise program to a stretching program, women who slept less at follow-up 
lost more weight [147]. In a US study of African-American and Hispanic adults that 
measured height and weight as well as subcutaneous and visceral fat, participants aged 18–
39 years who reported sleeping ≤5 hours per night experienced a larger increase in BMI, 
visceral fat and subcutaneous fat over 5 years compared to those aged 18–39 years who 
reported sleeping 6–7 hours per night [142]. In this same study, sleep duration was not 
associated with change in BMI or body fat among those aged 40 years or older [142]. A few 
studies reported sex differences in these associations, but which sex demonstrated a 
significant association was not consistent. For example, one study found an effect in men 
but not women [141] while another study saw an effect in women but not men [146]. Some, 
but not all, prospective studies found longitudinal associations between short sleep duration 
and increases in body weight and some found long sleep associated with greater weight gain 
or less weight loss. In addition, some of these studies suggest that there may be important 
age or gender differences, which require further examination.
3.2 Habitual sleep, appetite regulation and dietary behavior
Quite a few observational studies have examined the relationship between habitual sleep 
characteristics and levels of hormones involved in appetite regulation and/or dietary 
behavior. For example, in cross-sectional analysis of data from 740 men and women in the 
Quebec Family Study, leptin levels in those sleeping 5–6 hours per night were 
approximately 15–17% lower than predicted based on body fat alone [148]. The Wisconsin 
Sleep Cohort Study, which enrolled state employees aged 30–60 years, found that average 
habitual sleep duration was positively associated with leptin levels independently of BMI 
(beta = 0.11, p=0.01) [149]. The Women’s Health Initiative prospective Observational Study 
(WHI-OS), which enrolled postmenopausal women, found that women reporting ≤6 hours of 
sleep per night had lower fasting leptin concentrations than those reporting ≥8 hours of sleep 
per night adjusting for age, race, total body fat mass, and smoking status [150]. A fourth 
study found the opposite association; shorter sleep was associated with higher leptin levels. 
Specifically, this study examined fasting leptin levels and self-reported sleep duration in a 
sample of 254 Taiwanese adults and found that women sleeping <6.5 hours per night had an 
increased odds of having hyperlipidemia, defined as leptin levels in the upper quartile (OR = 
2.15, 95% CI 0.99, 4.78, p=.055) compared to women who slept at least 6.5 hours per night 
[151], although statistical significance was not quite reached. In men there was a similar but 
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not statistically significant association (OR = 4.98, 95% CI = 0.80–42.4, p=.096). Although 
most of these epidemiologic studies are consistent with the laboratory studies, other studies 
did not observe a significant association between self-reported sleep duration and leptin 
levels. Women in the Nurse’s Health Study returned a blood sample through the mail for 
assessment of leptin, and no association was found between self-reported sleep duration and 
leptin levels [152]. A study among 173 overweight, sedentary postmenopausal women aged 
50–74 year also did not observe a significant cross-sectional association between self-
reported sleep duration and fasting leptin or total ghrelin levels [147]. Finally, in a sleep 
extension study, 80 obese men and premenopausal women aged 18–50 years who were 
habitual short sleepers, no association was observed between average sleep duration or sleep 
efficiency from two weeks of wrist actigraphy recordings and fasting levels of leptin [153]. 
Two studies looked at appetite hormones in relation to sleep measured via PSG. The 
Wisconsin Sleep Cohort Study found that total sleep time from one night of 
polysomnography was inversely associated with ghrelin levels (beta = −0.69, p=0.008) but 
was not associated with leptin levels [149]. The Cleveland Family Study in adults (average 
age was 45 years) recorded one night of PSG with bedtimes were at 23:00 and wake times at 
6:45 for everyone and collected a fasting blood sample the following morning. They found 
that shorter TST and less REM sleep was associated with higher leptin levels, while SWS 
was not associated with leptin [154]. Because time in bed was the same for all individuals, it 
raises the question of how the measurements from one night of PSG are impacted by varying 
degrees of sleep debt within individuals. In other words, more REM sleep on the PSG could 
represent a REM rebound due to habitual sleep restriction, but habitual sleep duration was 
not reported or included in the analyses. The discrepant results concerning the association 
between sleep and leptin among these studies may be due to unmeasured confounding, 
differences in the association between sleep and appetite regulation in obese versus lean 
adults, or methodological issues such as self-reported sleep duration or sample collection.
Recently, many observational studies that have examined cross-sectional associations 
between habitual sleep duration, sleep quality or sleep problems and dietary intake or dietary 
patterns have been published (see Table 2 for details about these studies).
Among studies that relied on self-reported measures of sleep duration, shorter sleep 
durations were associated with greater total energy intake [150, 158, 159, 164, 166, 174], 
greater fat intake [163, 164], greater carbohydrate intake [158, 164] and greater alcohol 
intake [159, 160]. However, one study found lower caloric intake among people with 
insomnia [165] and two studies did not observe significant associations between habitual 
sleep and dietary intake [167, 168]. Several studies also found an association with optimal 
sleep (not short sleepers and/or better sleep quality) and healthier eating habits, such as 
eating breakfast, eating more regular meals, snacking less, eating at home more often and a 
greater variety of foods in the diet [156, 157, 162, 169–172]. Sleep disturbances among 
undergraduate students in Portugal were associated with more bulimic behavior and more 
social pressure to eat [155]. A study of 459 postmenopausal women used one week of wrist 
actigraphy to estimate sleep duration and found that sleep duration was negatively 
associated with amount of fat and calories consumed even after adjusting for BMI and 
physical activity [173]. These data indicate that at a specific level of BMI and physical 
activity, a woman who sleeps less consumes more calories, particularly from fat, on average 
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than a woman sleeping more. One study of adult women and men aged 19–45 years 
examined diet and sleep architecture using PSG and found that greater nocturnal (dinner 
plus any late night snacks) intake of fat was associated with lower sleep efficiency, greater 
REM latency, higher percentage of N2, lower percentage of REM and greater WASO after 
adjustment for age, gender, and socioeconomic status [161]. These results indicate that 
dietary intake can impact sleep and therefore the sleep-diet relationship may be 
bidirectional.
Differences in dietary intake could partly explain the association between short sleep 
duration and weight gain since dietary intake is associated with weight gain [175]. Recently, 
a meta-analysis compared the effect of alcohol, sleep deprivation and TV watching on food 
intake using 23 controlled, laboratory studies in healthy participants and found that the 
effect was greatest for alcohol (Cohen’s d = 1.03; 95% CI: 0.66, 1.4; P , 0.001) followed by 
sleep deprivation (Cohen’s d = 0.49; 95% CI: 0.11, 0.88; P , 0.05) [176]. Thus, habitual 
sleep loss could result in significant weight gain and one pathway though which this could 
happen is increasing energy intake.
3.3 Habitual sleep and diabetes risk
Several observational studies have reported cross-sectional associations between inadequate 
sleep and greater prevalence of diabetes or impaired glucose tolerance (see [177] for another 
recent review). Sleep quality is generally worse based on both subjective and objective 
estimates in people with type 2 diabetes (T2DM) [178]. Furthermore, among persons with 
T2DM, poorer glycemic control is associated with worse sleep quality and increased sleep 
disordered breathing [179–181]. Indeed, obstructive sleep apnea seems to be highly 
prevalent among patients with type 2 diabetes, with estimates ranging from 58 to 86% [20]. 
Although the results of these studies indicate that inadequate sleep is associated with 
diabetes, the direction of causality cannot be determined. Insufficient sleep may increase the 
risk of developing diabetes, as the laboratory studies suggest, or, conversely, having diabetes 
could impair sleep quality. Still if inadequate sleep can impair glucose control among 
patients with T2DM, then we need to understand better how to improve sleep in this 
population in order to identify whether such interventions can help to improve disease 
management and reduce the risk of complications.
A recent cross-sectional study in China simultaneously examined self-reported sleep 
duration (<6, 6–8 and >8 h) and subjective sleep quality (poor vs good) in relation to the 
presence of impaired fasting glucose (IFG) [182]. People with IFG are considered to have 
“pre-diabetes” and therefore at risk of developing T2DM. Compared to good sleepers who 
sleep 6–8 hours all other groups had increased odds of having IFG. Poor sleepers who sleep 
<6 hours had the highest odds (OR 6.37, 95%CI 4.66 to 8.67) and good sleepers who sleep 
>8 hours had the second highest odds of IFG (OR 3.17, 95%CI 2.29 to 4.41) [182]. These 
results highlight the importance of both sleep duration and sleep quality and underscore the 
need to understand better the health risk associated with long sleep.
Prospective studies provide stronger evidence for a causal link between inadequate sleep and 
the development of cardiometabolic diseases. Many studies reported increased odds of 
diabetes associated with short sleep duration (≤5h and/or ≤6h) and some observed a U-
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shaped association [183–187]. Furthermore, impaired sleep quality, such as difficulty 
initiating or maintaining sleep, has been associated with increased odds of developing 
diabetes in multiple studies [188–193]. Note that one study did not find a significant 
association between sleep and incident diabetes [194], while one study observed a 
significant association in men only [191]. A meta-analysis of 10 prospective studies 
examined the association between the incidence of diabetes and either short self-reported 
sleep duration, long self-reported sleep duration or subjective sleep disturbances [195]. The 
estimated pooled OR for short sleep was 1.28 (95% CI 1.03–1.6), however, there was a 
significant gender difference. The OR was 2.07 (95% CI 1.16–3.72) for men and 1.07 (95% 
CI 0.90–1.28) for women, indicating a stronger association among men. The pooled OR for 
long sleep was 1.48 (95% CI 1.13–1.96), indicating that overall there is a significant U-
shaped association between self-reported sleep duration and incident diabetes. Finally, both 
difficulty initiating sleep (pooled OR 1.57, 95% CI 1.25–1.97) and difficulty maintaining 
sleep (pooled OR 1.84, 95% CI 1.39–2.43) significantly predicted incident diabetes. Another 
meta-analysis examined the association between sleep duration and the metabolic syndrome, 
which is characterized by a combination of abdominal adiposity, dyslipidemia, elevated 
glucose and elevated blood pressure [196]. The authors identified 12 cross-sectional studies 
and 3 cohort studies, and estimated for short sleep durations (<5 to 6 hours/night) an OR of 
1.27 (95% CI 1.10, 1.48) in the cross-sectional studies and 1.62 (95% CI 0.74, 3.55) in the 3 
cohort studies. For long sleep durations (>8 to 10 hours/night), the OR was 1.23 (95% CI 
1.02, 1.49) in the cross-sectional studies and 1.62 (95% CI 0.86, 3.04) in the cohort studies. 
Thus the prospective associations were not significant in this meta-analysis of 3 studies. 
Overall, prospective epidemiologic studies suggest that subjective short or long sleep 
duration and poor sleep quality may predict the development of diabetes. Whether or not 
strategies to improve sleep can help reduce the risk of diabetes or improve glucose control in 
diabetes patients has yet to be determined.
3.4 Habitual sleep and cardiovascular disease risk
Self-reported short sleep and subjectively poor sleep quality have been associated with 
higher average blood pressure or higher prevalence of hypertension in cross-sectional 
studies [197–203]. Some of these studies also observed higher blood pressure among long 
sleepers [198, 203] and two of these studies observed a significant association only in 
women [200, 202]. Analysis of NHANES did find that self-reported short sleep duration was 
associated with both self-reported chronic disease (e.g. obesity and hypertension) as well as 
objectively-measured markers of chronic disease (e.g. obesity and hyperlipidemia) [204]. 
Two studies among elderly adults found no association between habitual sleep duration and 
blood pressure [205, 206], which suggests that associations between sleep and blood 
pressure may be modified by age. In one study that recorded wrist actigraphy among adults 
aged 35–50 years, shorter sleep duration and lower sleep quality were both associated with 
higher blood pressure [207]. A small study among 23 healthy, young adults aged 18–28 
years examined sleep efficiency based on wrist actigraphy in relation to nocturnal blood 
pressure dipping, which is a phenomenon associated with lower cardiovascular disease risk. 
They found that those with an average sleep efficiency <85% had a blunted nocturnal dip in 
systolic blood pressure compared to those with a sleep efficiency ≥85% [208]. Thus, cross-
sectional studies generally support a relationship between inadequate sleep and higher mean 
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blood pressure, but the causal direction cannot be determined and the strength of these 
associations may be modified by gender or age.
Several prospective epidemiologic studies have examined various cardiovascular outcomes 
in relation to habitual sleep. Analysis of the National Health and Nutrition Examination 
Survey (NHANES) data in the US found that short sleepers (≤5 hours per night) had 
increased odds of incident hypertension over 8–10 years (OR 1.32, 95% CI 1.02–1.71) 
compared to those reporting sleeping 7–8 hours per night after adjusting for numerous 
potential confounders [209]. In the study of adults aged 35–50 years that estimated sleep 
duration using actigraphy, shorter sleep was significantly associated with incident 
hypertension over 5 years (OR 0.72; 95% CI: 0.55, 0.95) [207] and incident coronary artery 
calcification (OR = 0.67 per hour, p=.011; 95% CI 0.49–0.91), which is a predictor of the 
development of coronary heart disease [210]. The Nurses’ Health Study found a 
significantly increased risk of incident coronary heart disease over 10 years associated with 
short (≤5 hours per night) self-reported sleep duration (risk ratio 1.45; 95% CI: 1.1–1.92) 
and long (≥9 hours per night) self-reported sleep duration (risk ratio 1.38; 95% CI: 1.03–
1.86) compared to those sleeping 8 hours per night [211]. A few studies have examined 
cardiovascular disease mortality in relation to self-reported sleep duration, but none found a 
significant association in fully adjusted models [212–214]. Poor subjective sleep quality was 
also associated with increased coronary artery disease mortality in men (RR: 3.1, 95%CI 
1.5–6.3) [212]. A study in the US of over 3,400 men and women 35 years of age or older 
reported a significant increase of cardiovascular disease events in those who complained of 
insomnia every day compared to those without any insomnia complaint (RR: 1.78, 95%CI 
1.03–3.08) [214]. Overall, there is some evidence that inadequate sleep is associated with 
cardiovascular disease and hypertension, but more rigorous studies are required to fully 
understand whether inadequate sleep actually leads to cardiovascular disease.
4. Summary
Experimental studies have found associations between sleep restriction or sleep 
fragmentation and impairments in glucose metabolism, alterations in appetite regulation, and 
increased inflammation, all of which would increase the risk of developing cardiometabolic 
disease. Observational studies have reported many cross-sectional associations between self-
reported short and/or long sleep duration and prevalent obesity, diabetes and hypertension. 
Fewer prospective studies exist and results are often mixed. Some demonstrated an 
association between sleep duration and weight gain or incident cardiometabolic disease.
Future Directions
Future research should focus on novel interventions to modify sleep. These studies could 
explicitly test whether extending sleep duration in short sleepers, restricting time in bed in 
long sleepers, improving sleep quality or treating sleep disorders such as OSA can lead to 
improvements in cardiometabolic health. Thus these interventions could be behavioral 
(changing bed times) or therapeutic (CPAP for OSA; medications for insomnia), depending 
on the specific sleep problem. Finally, studies should investigate whether sleep deficiency 
partially mediates cardiometabolic disease disparities between racial/ethnic or 
socioeconomic groups. If so, these novel interventions and the therapeutics to improve sleep 
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could help to reduce the associated health disparities, but they must be explicitly tested in 
the disadvantaged groups.
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Figure 1. Contributions of sleep debt in the pathophysiology of cardiometabolic diseases
Suboptimal sleep leads to metabolic dysfunction via activation of stress-immune axis. Acute 
sleep loss can trigger metabolic distress in immune cells, hepatocytes, adipocytes, 
endothelial cells and blood vessels by disturbing their homeostatic regulation. Prolonged 
activation along with defective counter-regulatory mechanisms as a consequence of chronic 
sleep deficiency may lead to the development of cardiometabolic diseases.
Natural killer (NK) cell, interleukin (IL), tumor necrosis factor (TNF), c-reactive protein 
(CRP), intercellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM), 
corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), sympathetic 
nervous system (SNS).
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t m
or
e.
 S
tre
tc
he
rs
 w
ho
 n
ap
pe
d 
le
ss
 
at
 fo
llo
w
 u
p 
ga
in
ed
 m
or
e 
w
ei
gh
t a
nd
 b
ot
h 
ex
er
ci
se
rs
 a
nd
 st
re
tc
he
rs
 w
ho
se
 tr
ou
bl
e 
fa
lli
ng
 a
sle
ep
 in
cr
ea
se
d 
ga
in
ed
 m
or
e 
w
ei
gh
t.
U
S
Lo
pe
z-
G
ar
ci
a 
A
JC
N
 2
00
8 
[1
40
]
2 
ye
ar
s
Se
lf-
re
po
rt
A
ge
: ≥
60
 y
ea
rs
n
=
3,
23
5 
m
en
 an
d 
w
om
en
In
 fu
lly
 a
dju
ste
d m
od
el,
 th
e a
sso
cia
tio
n b
etw
een
 sl
eep
 du
rat
ion
 an
d o
dd
s o
f g
ain
ing
 
≥5
 k
g 
ov
er
 th
e f
ol
lo
w
-u
p 
pe
rio
d 
w
as
 si
gn
ifi
ca
nt
 in
 w
om
en
 o
nl
y:
 ≤
5 
ho
ur
s/n
ig
ht
: 
3.
41
 (1
.34
–8
.69
); 
6 h
ou
rs/
nig
ht:
 no
t s
ign
ifi
ca
nt;
 7 
ho
urs
/ni
gh
t r
efe
ren
t; 8
 ho
urs
/
n
ig
ht
: 3
.0
3 
(1.
29
–7
.12
); 
9 h
ou
rs/
nig
ht 
3.7
7 (
1.5
5–
9.1
7);
 ≥1
0 h
ou
rs/
nig
ht 
no
t 
sig
ni
fic
an
t.
Sp
ai
n
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Ta
bl
e 
2
Su
m
m
ar
y 
of
 st
ud
ie
s t
ha
t e
xa
m
in
ed
 th
e 
as
so
ci
at
io
n 
be
tw
ee
n 
ha
bi
tu
al
 sl
ee
p 
an
d 
di
et
ar
y 
pa
tte
rn
s o
r b
eh
av
io
r.
St
ud
y
n
A
ge
 r
an
ge
 o
r 
m
ea
n 
(S
D)
 an
d s
ex
Sl
ee
p 
M
ea
su
re
D
ie
ta
ry
 M
ea
su
re
R
es
ul
t s
um
m
ar
y
So
ar
es
 e
t a
l, 
20
11
 
[1
55
]
87
0
U
nd
er
gr
ad
ua
te
 st
ud
en
ts 
ag
ed
 1
7–
25
 y
ea
rs
 in
 
Po
rtu
ga
l
2 
qu
es
tio
ns
 a
dd
re
ss
in
g 
di
ffi
cu
lti
es
 
in
iti
at
in
g 
sle
ep
 (D
IS
) a
nd
 di
ffi
cu
ltie
s 
m
ai
nt
ai
ni
ng
 sl
ee
p 
(D
M
S)
. A
 sl
ee
p 
di
stu
rb
an
ce
 in
de
x 
(S
DI
) w
as 
the
 su
m 
of 
D
IS
 a
nd
 D
M
S 
sc
or
es
Ea
tin
g 
A
tti
tu
de
s T
es
t-4
0 
us
ed
 to
 
m
ea
su
re
: 
(1)
 di
et 
co
nc
ern
s (
DC
), (
2) 
bu
lim
ic
 b
eh
av
io
r (
BB
) a
nd
 (3
) s
oc
ial
 
pr
es
su
re
 to
 e
at
 (S
PE
)
In
 th
e 
to
ta
l s
am
pl
e 
an
d 
in
 m
al
es
, B
B 
an
d 
SP
E 
di
m
en
sio
ns
 w
er
e 
sig
ni
fic
an
tly
 a
ss
oc
ia
te
d 
w
ith
 
sle
ep
 d
iff
ic
ul
tie
s (
DI
S, 
DM
S, 
SD
I).
 In
 fe
ma
les
, 
B
B
 w
as
 si
gn
ifi
ca
nt
ly
 a
ss
oc
ia
te
d 
w
ith
 sl
ee
p 
di
ffi
cu
lti
es
 (S
DI
, D
IS
; P
 < 
0.0
1).
N
ak
ad
e 
et
 a
l, 
20
09
 
[1
56
]
80
0
Fe
m
al
e 
stu
de
nt
s a
ge
d 
18
–2
9 
ye
ar
s i
n 
Ja
pa
n
he
al
th
y 
sle
ep
 h
ab
its
 b
as
ed
 o
n 
se
lf-
re
po
rte
d 
sle
ep
 q
ua
lit
y,
 sl
ee
p 
ho
ur
s, 
re
gu
la
rit
y 
of
 sl
ee
p-
w
ak
e 
cy
cl
es
, a
nd
 
sle
ep
 sa
tis
fa
ct
io
n
ex
ce
rp
t f
ro
m
 a
n 
Ex
am
in
at
io
n 
of
 
Ea
tin
g 
H
ab
its
 to
 a
ss
es
s d
rin
ki
ng
, 
sm
o
ki
ng
, a
nd
 re
gu
la
rit
y 
of
 m
ea
ls
Pa
rti
ci
pa
nt
s w
ith
 h
ea
lth
ie
r s
le
ep
 h
ab
its
 w
er
e 
sig
ni
fic
an
tly
 m
or
e 
lik
el
y 
to
 e
at
 b
re
ak
fa
st 
re
gu
la
rly
 a
nd
 le
ss
 li
ke
ly
 to
 e
at
 “
m
id
ni
gh
t s
na
ck
s”
H
ic
ks
 e
t a
l, 
19
86
 
[1
57
]
31
Co
lle
ge
 st
ud
en
ts 
in
 th
e 
U
S 
(ag
e n
ot 
sp
ec
ifi
ed
)
Se
lf-
re
po
rt
M
ea
l r
ec
or
d 
fo
r o
ne
 d
ay
Sh
or
t-s
le
ep
er
s (
av
era
ge
 6h
/ni
gh
t) 
we
re 
mo
re 
lik
el
y 
to
 d
ev
ia
te
 fr
om
 th
e 
no
rm
al
 th
re
e 
m
ea
ls/
da
y 
pa
tte
rn
, a
nd
 th
ey
 sh
ow
ed
 a
 te
nd
en
cy
 to
 e
at
 m
or
e 
sm
al
l m
ea
ls 
or
 sn
ac
ks
 th
an
 lo
ng
er
 sl
ee
pe
rs
 (≥
8h
/
n
ig
ht
).
H
ag
hi
gh
at
do
os
t e
t 
al
, 2
01
2 
[1
58
]
41
0
Fe
m
al
e 
stu
de
nt
s a
ge
d 
18
–2
8 
y 
in
 Ir
an
Sl
ee
p 
du
ra
tio
n 
ba
se
d 
on
 p
hy
sic
al
 
ac
tiv
ity
 re
co
rd
 fo
r 2
4 
h 
du
rin
g 
a 
w
ee
kd
ay
 a
nd
 w
ee
ke
nd
 d
ay
Fo
od
 fr
eq
ue
nc
y 
qu
es
tio
nn
ai
re
Co
m
pa
re
d 
to
 su
bje
cts
 in
 th
e h
igh
est
 te
rtil
e o
f 
sle
ep
 d
ur
at
io
n 
(>
8 h
/d)
, s
ub
jec
ts 
in 
the
 lo
we
st 
te
rt
ile
 o
f s
le
ep
 d
ur
at
io
n 
(<
6 h
/d)
 ha
d a
 hi
gh
er 
in
ta
ke
 o
f e
ne
rg
y 
(24
06
 ± 
82
5 v
ers
us
 20
92
 ± 
70
0 
kc
al
/d
; P
 <
 0
.0
1).
 M
ea
n p
erc
en
tag
es 
of 
pro
tei
n 
an
d 
ca
rb
oh
yd
ra
te
 in
ta
ke
 w
er
e 
14
%
 a
nd
 5
8%
 in
 
th
e 
lo
w
es
t t
er
til
e 
an
d 
19
%
 an
d 
51
.6
%
 in
 th
e 
hi
gh
es
t, 
re
sp
ec
tiv
el
y 
(P
 < 
0.0
5).
 In
tak
e o
f f
rui
ts,
 
w
ho
le
 g
ra
in
s, 
be
an
s, 
ni
ac
in
, v
ita
m
in
 C
, a
nd
 
v
ita
m
in
 B
12
 w
as
 lo
w
er
 a
m
on
g 
th
os
e 
in
 th
e 
lo
w
es
t t
er
til
e 
co
m
pa
re
d 
to
 th
e 
hi
gh
es
t t
er
til
e.
 
N
ot
e 
th
at
 th
es
e 
di
ffe
re
nc
es
 a
re
 a
dju
ste
d o
nly
 fo
r 
to
ta
l e
ne
rg
y 
in
ta
ke
.
G
al
li 
et
 a
l, 
20
13
 
[1
59
]
11
8
O
be
se
 m
en
 a
nd
 
pr
em
en
op
au
sa
l w
om
en
 
ag
ed
 1
8–
50
 y
ea
rs
 w
ho
 
ar
e 
sh
or
t s
le
ep
er
s a
nd
 
en
ro
lle
d 
in
 a
 sl
ee
p 
ex
te
ns
io
n 
stu
dy
 in
 th
e 
U
S
14
-d
ay
s o
f w
ris
t a
ct
ig
ra
ph
y 
an
d 
as
se
ss
m
en
t o
f s
le
ep
 a
pn
ea
 w
as
 a
ss
es
se
d 
u
sin
g 
a 
po
rta
bl
e 
sc
re
en
in
g 
de
vi
ce
3-
da
y 
fo
od
 d
ia
ry
A
fte
r a
dju
stm
en
t fo
r a
pn
ea 
sev
eri
ty,
 ag
e, 
ge
nd
er,
 
B
M
I, 
an
d 
ra
ce
/e
th
ni
ci
ty
 a
 3
0-
m
in
 sh
or
te
r s
le
ep
 
du
ra
tio
n 
w
as
 a
ss
oc
ia
te
d 
w
ith
 8
3-
kc
al
 g
re
at
er
 
en
er
gy
 in
ta
ke
 o
n 
av
er
ag
e.
 R
D
I w
as
 in
ve
rs
el
y 
re
la
te
d 
to
 c
ar
bo
hy
dr
at
e 
in
ta
ke
 a
nd
 p
os
iti
ve
ly
 
as
so
ci
at
ed
 w
ith
 fa
t i
nt
ak
e.
 S
le
ep
 d
ur
at
io
n 
w
as
 
al
so
 in
ve
rs
el
y 
as
so
ci
at
ed
 w
ith
 a
lc
oh
ol
 in
ta
ke
 
af
te
r a
dju
sti
ng
 fo
r a
ge
, g
en
de
r a
nd
 B
MI
 or
 
et
hn
ic
ity
/ra
ce
.
Ch
ap
ut
 e
t a
l, 
20
12
 
[1
60
]
70
3
Qu
eb
ec
 Fa
mi
ly 
Stu
dy
: 
m
en
 a
n
d 
w
om
en
 a
ge
d 
18
–6
4 
ye
ar
s i
n 
Ca
na
da
Se
lf-
re
po
rt
3-
da
y 
fo
od
 re
co
rd
A
fte
r a
dju
sti
ng
 fo
r c
ov
ari
ate
s, s
ho
rt s
lee
p 
du
ra
tio
n 
(≤
77
h/n
igh
t) 
wa
s a
sso
cia
ted
 w
ith
 an
 
in
cr
ea
se
 in
 th
e 
od
ds
 o
f e
xc
ee
di
ng
 th
e 
re
co
m
m
en
da
tio
ns
 w
ee
kl
y 
al
co
ho
l i
nt
ak
e 
of
 1
4 
dr
in
ks
 fo
r m
en
 a
nd
 7
 d
rin
ks
 fo
r w
om
en
 
co
m
pa
re
d 
to
 th
os
e 
sle
ep
in
g 
be
tw
ee
n 
7 
an
d 
8 
h 
(O
R 
1.8
7, 
95
% 
CI
 1.
03
–3
.54
, b
oth
 se
xe
s 
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St
ud
y
n
A
ge
 r
an
ge
 o
r 
m
ea
n 
(S
D)
 an
d s
ex
Sl
ee
p 
M
ea
su
re
D
ie
ta
ry
 M
ea
su
re
R
es
ul
t s
um
m
ar
y
co
m
bi
ne
d).
 L
on
g s
lee
pe
rs 
(≥
9h
/n
ig
ht
) d
id 
no
t d
iff
er 
fro
m 
7–
8 h
 sl
ee
pe
rs.
 
9h
/n
ig
ht
) d
id 
no
t d
iff
er 
fro
m 
7–
8 h
 sl
ee
pe
rs.
Cr
isp
im
 e
t a
l, 
20
11
 
[1
61
]
52
W
om
en
 a
nd
 m
en
 a
ge
d 
19
–4
5 
ye
ar
s i
n 
Br
az
il
N
oc
tu
rn
al
 p
ol
ys
om
no
gr
ap
hy
 (P
SG
)
3-
da
y 
fo
od
 d
ia
ry
 im
m
ed
ia
te
ly
 p
rio
r t
o 
th
e 
PS
G
G
re
at
er
 n
oc
tu
rn
al
 in
ta
ke
 (d
inn
er 
plu
s a
ny
 la
te 
n
ig
ht
 sn
ac
ks
) o
f f
at 
wa
s a
sso
cia
ted
 w
ith
 lo
we
r 
sle
ep
 e
ffi
ci
en
cy
, g
re
at
er
 R
EM
 la
te
nc
y,
 h
ig
he
r 
pe
rc
en
ta
ge
 o
f N
2,
 lo
w
er
 p
er
ce
nt
ag
e 
of
 R
EM
 a
nd
 
gr
ea
te
r W
A
SO
 a
fte
r a
dju
stm
en
t fo
r a
ge
, g
en
de
r, 
an
d 
so
ci
oe
co
no
m
ic
 st
at
us
Im
ak
i e
t a
l 2
00
2 
[1
62
]
12
,3
33
M
al
e 
em
pl
oy
ee
s a
ge
d 
20
–5
9 
ye
ar
s a
t a
 
ch
em
ic
al
 p
la
nt
 in
 Ja
pa
n
Se
lf-
re
po
rt 
w
ith
 3
 re
sp
on
se
 o
pt
io
ns
: <
6;
 
6.
1 
to
 8
.9
; ≥
9 
ho
ur
s
di
et
ar
y 
ha
bi
ts 
as
se
ss
ed
 w
ith
 7
 it
em
s: 
(1)
 nu
mb
er 
of 
me
als
 pe
r d
ay
 (1
, 3
 
tim
es
; 2
, t
w
ic
e;
 3
, i
rre
gu
la
r);
 (2
) s
na
ck
 
be
tw
ee
n 
m
ea
ls 
(ye
s o
r n
o);
 (3
) e
ati
ng
 
o
u
t (
fre
qu
en
tly
 or
 ra
rel
y);
 (4
) d
ail
y 
di
et
 p
at
te
rn
 (r
eg
ula
r o
r i
rre
gu
lar
); 
(5)
 
in
ta
ke
 o
f v
eg
et
ab
le
s i
n 
th
e 
di
et
 (a
mp
le 
o
r 
n
o
n
e);
 (6
) s
ea
so
nin
g o
f f
oo
d 
(st
ron
gly
 sa
lty
, c
on
ve
nti
on
al 
or 
lig
htl
y 
se
as
o
n
ed
); 
(7)
 oi
ly 
foo
d i
tem
s 
(pr
efe
rre
d o
r n
ot 
de
sir
ed
 m
uc
h).
Sh
or
t s
le
ep
er
s (
≤6
 ho
urs
 pe
r n
igh
t) 
we
re 
mo
re 
lik
el
y 
to
 e
at
 m
ea
ls 
irr
eg
ul
ar
ly
, s
na
ck
 b
et
w
ee
n 
m
ea
ls 
an
d 
ea
t o
ut
sid
e 
th
e 
ho
m
e 
th
an
 th
os
e 
re
po
rti
ng
 sl
ee
pi
ng
 b
et
w
ee
n 
6.
1 
an
d 
8.
9 
ho
ur
s. 
(L
on
g s
lee
pe
rs 
we
re 
no
t a
na
lyz
ed
 be
ca
us
e t
he
 
pr
ev
al
en
ce
 w
as
 o
nl
y 
1%
)
Sh
i e
t a
l, 
20
08
 
[1
63
]
28
28
A
du
lts
 ≥
20
 y
ea
rs
 o
ld
 in
 
Ch
in
a
Se
lf-
re
po
rt
3-
da
y 
fo
od
 re
co
rd
s.
In
 a
dju
ste
d m
od
els
, su
bje
cts
 w
ho
 sl
ep
t fo
r <
 7 
h/
n
ig
ht
 h
ad
 si
gn
ifi
ca
nt
ly
 h
ig
he
r p
er
ce
nt
ag
e 
of
 
en
er
gy
 in
ta
ke
 fr
om
 fa
t (
1.5
% 
mo
re 
pe
r d
ay
) a
nd
 
sig
ni
fic
an
tly
 lo
w
er
 p
er
ce
nt
ag
e 
fro
m
 
ca
rb
oh
yd
ra
te
s (
1.8
% 
pe
r d
ay
) t
ha
n t
ho
se 
wh
o 
sle
pt
 fo
r 7
–9
 h
 p
er
 d
ay
.
Pa
rv
an
eh
 e
t a
l, 
20
14
 [1
64
]
22
6
M
en
 a
nd
 w
om
en
 a
ge
d 
20
–5
5 
ye
ar
s o
ld
 in
 Ir
an
Sl
ee
p 
H
ab
it 
H
ea
rt 
Qu
est
ion
na
ire
Th
re
e-
da
ys
 o
f 2
4-
ho
ur
 d
ie
ta
ry
 re
ca
ll
Sl
ee
p 
du
ra
tio
n 
sh
ow
ed
 si
gn
ifi
ca
nt
 b
ut
 w
ea
k 
po
sit
iv
e 
co
rre
la
tio
ns
 w
ith
 e
ne
rg
y 
in
ta
ke
 (r
 = 
0.
17
4),
 ca
rbo
hy
dra
te 
int
ak
e (
r =
 0.
15
4) 
an
d f
at 
in
ta
ke
 (r
 = 
0.1
41
).
Za
de
h 
et
 a
l, 
20
11
 
[1
65
]
87
M
en
 &
 w
om
en
 a
ge
d 
21
–
45
 y
ea
rs
 in
 In
di
a
In
so
m
ni
a 
Sc
re
en
in
g 
In
de
x.
3-
da
y 
fo
od
 d
ia
ry
Pr
es
en
ce
 o
f i
ns
om
ni
a 
w
as
 a
ss
oc
ia
te
d 
w
ith
 lo
w
er
 
ca
lo
ric
 in
ta
ke
, l
ow
er
 p
ro
te
in
 in
ta
ke
 a
nd
 lo
w
er
 
ca
rb
oh
yd
ra
te
 in
ta
ke
 c
om
pa
re
d 
to
 n
or
m
al
 
sle
ep
er
s.
Pa
tte
rs
on
 e
t a
l, 
20
14
 [1
66
]
22
3
U
CL
A
 E
ne
rg
et
ic
s S
tu
dy
: 
A
fri
ca
n-
A
m
er
ic
an
 a
nd
 
n
o
n
-H
isp
an
ic
 w
hi
te
s 
ag
ed
 2
1–
69
 y
 in
 th
e U
S
Se
lf-
re
po
rt
En
er
gy
 in
ta
ke
 =
 to
ta
l e
ne
rg
y 
ex
pe
nd
itu
re
 fr
om
 d
ou
bl
y 
la
be
le
d 
w
at
er
 te
ch
ni
qu
e
Co
m
pa
re
d 
w
ith
 ≤
6 
h/
d,
 p
ar
tic
ip
an
ts 
w
ho
 re
po
rte
d 
lo
ng
er
 sl
ee
p 
co
ns
um
ed
 fe
w
er
 to
ta
l k
ilo
ca
lo
rie
s 
pe
r d
ay
 (−
50
 kc
al/
da
y f
or 
7 h
, −
41
 kc
al/
da
y f
or 
8 
h,
 a
nd
 1
87
 k
ca
l/d
ay
 fo
r ≥
9 
h.
R
on
to
ya
nn
i e
t a
l, 
20
07
 [1
67
]
30
W
om
en
 3
0–
60
 y
ea
rs
 o
f 
ag
e 
in
 G
re
ec
e
Sl
ee
p 
H
ab
its
 Q
ue
sti
on
na
ire
 an
d a
 7-
d 
sle
ep
 d
ia
ry
Tw
o 
24
-h
 d
ie
ta
ry
 re
ca
ll
W
ea
k 
po
sit
iv
e 
as
so
ci
at
io
n 
be
tw
ee
n 
sle
ep
 
du
ra
tio
n 
an
d 
sa
tu
ra
te
d 
fa
t (
r =
 0.
39
2, 
P <
 0.
05
). 
N
o 
sig
ni
fic
an
t a
ss
oc
ia
tio
n 
be
tw
ee
n 
sle
ep
 
du
ra
tio
n 
an
d 
en
er
gy
 in
ta
ke
 o
r a
 p
re
fe
re
nc
e 
fo
r f
at
 
o
r 
ca
rb
oh
yd
ra
te
 c
on
su
m
pt
io
n.
H
ar
t e
t a
l, 
20
12
 
[1
68
]
31
8
W
om
en
 in
 th
e 
U
S 
in
 
cl
in
ic
al
 w
ei
gh
t l
os
s t
ria
l 
w
ho
 w
er
e 
≥ 
30
 y
ea
rs
 o
ld
, 
o
v
er
w
ei
gh
t o
r o
be
se
 a
nd
 
re
po
rte
d 
≥ 
10
 u
rin
ar
y 
PS
QI
 fo
r t
im
e i
n b
ed
 (T
IB
)
B
lo
ck
 F
oo
d 
Fr
eq
ue
nc
y 
Qu
est
ion
na
ire
TI
B
 w
as
 n
ot
 a
ss
oc
ia
te
d 
w
ith
 a
ny
 o
f t
he
 d
ie
ta
ry
 
co
m
po
sit
io
n 
va
ria
bl
es
 m
ea
su
re
d 
on
 th
e 
Bl
oc
k 
FF
Q.
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St
ud
y
n
A
ge
 r
an
ge
 o
r 
m
ea
n 
(S
D)
 an
d s
ex
Sl
ee
p 
M
ea
su
re
D
ie
ta
ry
 M
ea
su
re
R
es
ul
t s
um
m
ar
y
in
co
nt
in
en
t e
pi
so
de
s p
er
 w
ee
k 
in
co
nt
in
en
t e
pi
so
de
s p
er
 w
ee
k
K
im
 e
t a
l, 
20
11
 
[1
69
]
27
,9
83
Si
ste
rs
 o
f w
om
en
 w
ho
 
ha
d 
br
ea
st 
ca
nc
er
. A
ge
s 
35
–7
4 
ye
ar
s.
Se
lf-
re
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 m
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at
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ou
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 d
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 m
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 d
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m
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 p
at
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r f
at
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e p
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at
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 b
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ra
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 o
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 d
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ca
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d m
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 c
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s p
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 c
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 d
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 re
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 m
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 re
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 re
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 d
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 d
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f d
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